The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer (MIBC).

CG Oncology, Inc. ( ($CGON) ) has released its Q4 earnings. Here is a breakdown of the information CG Oncology, Inc. presented to its investors.

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...

Learn more about the role of Tuberculosis in cancer and how a simple vaccine supports the immune system to fight it.

The first barrier Grivas notes is limited infusion room capacity and the need for rapid chair turnover. Other external barriers for patients include transportation and lodging. Grivas highlights that ...

Discover how a TB vaccine could revolutionise bladder cancer treatment. Find out more about this groundbreaking study.

Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly ...

The following is a summary of “Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guérin) therapy: a retrospective observational study,” published in the ...

Cancer impacts millions globally, with lifestyle choices such as smoking, diet, physical activity, alcohol consumption, sun exposure, stress, and slee ...

Get Instant Summarized Text (Gist) An FDA-approved drug, trametinib, has shown significant effectiveness in treating canine oral squamous cell carcinomas, the most common oral cancer in dogs. The ...

A noninvasive urinary DNA methylation test demonstrated high sensitivity for detecting high-grade or invasive bladder cancer. A urinary DNA methylation test displayed superior sensitivity for ...